The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Philipson, Louis
One or more keywords matched the following items that are connected to Philipson, Louis
Item TypeName
Concept Hypoglycemic Agents
Academic Article Update in neonatal diabetes.
Academic Article Neonatal diabetes mellitus: a model for personalized medicine.
Academic Article Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
Academic Article Calcium-activated and voltage-gated potassium channels of the pancreatic islet impart distinct and complementary roles during secretagogue induced electrical responses.
Academic Article ß-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion.
Academic Article Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons.
Academic Article Lean versus obese diabetes mellitus patients in the United States minority population.
Academic Article The role of ß cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
Academic Article Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes.
Academic Article External Validation of the Newly Developed BETA-2 Scoring System for Pancreatic Islet Graft Function Assessment.
Academic Article Harnessing heterogeneity in type 2 diabetes mellitus.
Academic Article Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Academic Article Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.
Academic Article Approach to the Patient with MODY-Monogenic Diabetes.
Academic Article The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
Academic Article Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
Academic Article First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Academic Article First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
Search Criteria
  • Hypoglycemic Agents